Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Change in Account Payables (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Change in Account Payables for 6 consecutive years, with -$288000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Account Payables rose 25.77% year-over-year to -$288000.0, compared with a TTM value of $479000.0 through Dec 2025, up 33.43%, and an annual FY2025 reading of $479000.0, up 33.43% over the prior year.
  • Change in Account Payables was -$288000.0 for Q4 2025 at Viemed Healthcare, up from -$831000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $2.3 million in Q3 2021 and bottomed at -$2.5 million in Q4 2021.
  • Average Change in Account Payables over 5 years is -$10300.0, with a median of $74000.0 recorded in 2021.
  • The sharpest move saw Change in Account Payables skyrocketed 394.74% in 2022, then tumbled 604.02% in 2023.
  • Year by year, Change in Account Payables stood at -$2.5 million in 2021, then skyrocketed by 85.99% to -$351000.0 in 2022, then plummeted by 72.08% to -$604000.0 in 2023, then skyrocketed by 35.76% to -$388000.0 in 2024, then grew by 25.77% to -$288000.0 in 2025.
  • Business Quant data shows Change in Account Payables for VMD at -$288000.0 in Q4 2025, -$831000.0 in Q3 2025, and $422000.0 in Q2 2025.